Literature DB >> 23117839

Detection limits of DNA copy number alterations in heterogeneous cell populations.

Oscar Krijgsman1, Daniëlle Israeli, Hendrik F van Essen, Paul P Eijk, Michel L M Berens, Clemens H M Mellink, Aggie W Nieuwint, Marjan M Weiss, Renske D M Steenbergen, Gerrit A Meijer, Bauke Ylstra.   

Abstract

BACKGROUND: Array Comparative Genomic Hybridization (aCGH) is a widely used technique to assess chromosomal copy number alterations. Chromosomal content, however, is often not uniform throughout cell populations. Here we evaluated to what extent aCGH can detect DNA copy number alterations in heterogeneous cell populations. A systematic evaluation is currently lacking, despite its importance in diagnostics and research. The detection limits reported are a compound of analytical software and laboratory techniques and do not account for the number of probes in relation to sample homogeneity.
METHODS: Detection limits were explored with DNA isolated from a patient with intellectual disability (ID) and from tumor cell line BT474. Both were diluted with increasing amounts of normal DNA to simulate different levels of cellularity. Samples were hybridized on microarrays containing 180,880 oligonucleotides evenly distributed over the genome (spacing ~17 kb).
RESULTS: Single copy number alterations, represented by down to 249 probes (4 Mb) and present in 10 % of a cell population, could be detected. Alterations encompassing as few as 14 probes (~238 Kb) could also be detected, but for this a 35 % mosaic level was required.
CONCLUSIONS: DNA copy number alterations can be detected in cell populations containing 10 % abnormal cells. Detection of sub-megabase alterations requires a higher percentage of abnormal cells or microarrays with a higher probe density.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23117839     DOI: 10.1007/s13402-012-0108-2

Source DB:  PubMed          Journal:  Cell Oncol (Dordr)        ISSN: 2211-3428            Impact factor:   6.730


  38 in total

Review 1.  Array comparative genomic hybridization and its applications in cancer.

Authors:  Daniel Pinkel; Donna G Albertson
Journal:  Nat Genet       Date:  2005-06       Impact factor: 38.330

2.  Detection of low-level mosaicism by array CGH in routine diagnostic specimens.

Authors:  Blake C Ballif; Emily A Rorem; Kyle Sundin; Matt Lincicum; Shannon Gaskin; Justine Coppinger; Catherine D Kashork; Lisa G Shaffer; Bassem A Bejjani
Journal:  Am J Med Genet A       Date:  2006-12-15       Impact factor: 2.802

3.  Cross-platform array comparative genomic hybridization meta-analysis separates hematopoietic and mesenchymal from epithelial tumors.

Authors:  K Jong; E Marchiori; A van der Vaart; S-F Chin; B Carvalho; M Tijssen; P P Eijk; P van den Ijssel; H Grabsch; P Quirke; J J Oudejans; G A Meijer; C Caldas; B Ylstra
Journal:  Oncogene       Date:  2006-08-28       Impact factor: 9.867

4.  High-resolution copy number profiling by array CGH using DNA isolated from formalin-fixed, paraffin-embedded tissues.

Authors:  Hendrik F van Essen; Bauke Ylstra
Journal:  Methods Mol Biol       Date:  2012

5.  Across array comparative genomic hybridization: a strategy to reduce reference channel hybridizations.

Authors:  Tineke E Buffart; Daniëlle Israeli; Marianne Tijssen; Sjoerd J Vosse; Alan Mrsić; Gerrit A Meijer; Bauke Ylstra
Journal:  Genes Chromosomes Cancer       Date:  2008-11       Impact factor: 5.006

6.  Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers.

Authors:  Rebecca J Leary; Jimmy C Lin; Jordan Cummins; Simina Boca; Laura D Wood; D Williams Parsons; Siân Jones; Tobias Sjöblom; Ben-Ho Park; Ramon Parsons; Joseph Willis; Dawn Dawson; James K V Willson; Tatiana Nikolskaya; Yuri Nikolsky; Levy Kopelovich; Nick Papadopoulos; Len A Pennacchio; Tian-Li Wang; Sanford D Markowitz; Giovanni Parmigiani; Kenneth W Kinzler; Bert Vogelstein; Victor E Velculescu
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-13       Impact factor: 11.205

7.  The pitfalls of platform comparison: DNA copy number array technologies assessed.

Authors:  Christina Curtis; Andy G Lynch; Mark J Dunning; Inmaculada Spiteri; John C Marioni; James Hadfield; Suet-Feung Chin; James D Brenton; Simon Tavaré; Carlos Caldas
Journal:  BMC Genomics       Date:  2009-12-08       Impact factor: 3.969

8.  High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays.

Authors:  D Pinkel; R Segraves; D Sudar; S Clark; I Poole; D Kowbel; C Collins; W L Kuo; C Chen; Y Zhai; S H Dairkee; B M Ljung; J W Gray; D G Albertson
Journal:  Nat Genet       Date:  1998-10       Impact factor: 38.330

9.  Detection of low-level mosaicism and placental mosaicism by oligonucleotide array comparative genomic hybridization.

Authors:  Stuart A Scott; Ninette Cohen; Tracy Brandt; Gokce Toruner; Robert J Desnick; Lisa Edelmann
Journal:  Genet Med       Date:  2010-02       Impact factor: 8.822

10.  The carcinoma-stromal ratio of colon carcinoma is an independent factor for survival compared to lymph node status and tumor stage.

Authors:  Wilma E Mesker; Jan M C Junggeburt; Karoly Szuhai; Pieter de Heer; Hans Morreau; Hans J Tanke; Rob A E M Tollenaar
Journal:  Cell Oncol       Date:  2007       Impact factor: 6.730

View more
  14 in total

1.  Guidelines for cytogenetic investigations in tumours.

Authors:  Rosalind J Hastings; Nick Bown; Maria G Tibiletti; Maria Debiec-Rychter; Roberta Vanni; Blanca Espinet; Nadine van Roy; Paul Roberts; Eva van den Berg-de-Ruiter; Alain Bernheim; Jacqueline Schoumans; Steve Chatters; Zuzana Zemanova; Marian Stevens-Kroef; Annet Simons; Sverre Heim; Marta Salido; Bauke Ylstra; David R Betts
Journal:  Eur J Hum Genet       Date:  2015-03-25       Impact factor: 4.246

2.  2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) inhibits human ovarian cancer cell proliferation.

Authors:  Yan Li; Kai Wang; Yi-Zhou Jiang; Xin-Wen Chang; Cai-Feng Dai; Jing Zheng
Journal:  Cell Oncol (Dordr)       Date:  2014-11-18       Impact factor: 6.730

3.  Somatic mutations of amino acid metabolism-related genes in gastric and colorectal cancers and their regional heterogeneity--a short report.

Authors:  Hye Rim Oh; Chang Hyeok An; Nam Jin Yoo; Sug Hyung Lee
Journal:  Cell Oncol (Dordr)       Date:  2014-12-02       Impact factor: 6.730

4.  The contribution of 7q33 copy number variations for intellectual disability.

Authors:  Fátima Lopes; Fátima Torres; Sally Ann Lynch; Arminda Jorge; Susana Sousa; João Silva; Paula Rendeiro; Purificação Tavares; Ana Maria Fortuna; Patrícia Maciel
Journal:  Neurogenetics       Date:  2017-12-19       Impact factor: 2.660

5.  Prognostic and predictive value of copy number alterations in invasive breast cancer as determined by multiplex ligation-dependent probe amplification.

Authors:  Sanaz Tabarestani; Sayyed Mohammad Hossein Ghaderian; Hamid Rezvani; Reza Mirfakhraie; Abdolali Ebrahimi; Hamid Attarian; Jahangir Rafat; Mojtaba Ghadyani; Hossein Afshin Alavi; Naser Kamalian; Afshin Rakhsha; Eznollah Azargashb
Journal:  Cell Oncol (Dordr)       Date:  2014-02-27       Impact factor: 6.730

6.  Phenotypic and functional consequences of haploinsufficiency of genes from exocyst and retinoic acid pathway due to a recurrent microdeletion of 2p13.2.

Authors:  Jiadi Wen; Fátima Lopes; Gabriela Soares; Sandra A Farrell; Cara Nelson; Ying Qiao; Sally Martell; Chansonette Badukke; Carlos Bessa; Bauke Ylstra; Suzanne Lewis; Nina Isoherranen; Patricia Maciel; Evica Rajcan-Separovic
Journal:  Orphanet J Rare Dis       Date:  2013-07-10       Impact factor: 4.123

7.  Chromosomal copy number aberrations in colorectal metastases resemble their primary counterparts and differences are typically non-recurrent.

Authors:  Leonie J M Mekenkamp; Josien C Haan; Daniëlle Israeli; Hendrik F B van Essen; Jeroen R Dijkstra; Patricia van Cleef; Cornelis J A Punt; Gerrit A Meijer; Iris D Nagtegaal; Bauke Ylstra
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

8.  DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly.

Authors:  Ilari Scheinin; Daoud Sie; Henrik Bengtsson; Mark A van de Wiel; Adam B Olshen; Hinke F van Thuijl; Hendrik F van Essen; Paul P Eijk; François Rustenburg; Gerrit A Meijer; Jaap C Reijneveld; Pieter Wesseling; Daniel Pinkel; Donna G Albertson; Bauke Ylstra
Journal:  Genome Res       Date:  2014-09-18       Impact factor: 9.043

9.  Spatial and temporal evolution of distal 10q deletion, a prognostically unfavorable event in diffuse low-grade gliomas.

Authors:  Hinke F van Thuijl; Ilari Scheinin; Daoud Sie; Agusti Alentorn; Hendrik F van Essen; Martijn Cordes; Ruth Fleischeuer; Anja M Gijtenbeek; Guus Beute; Wimar A van den Brink; Gerrit A Meijer; Miek Havenith; Ahmed Idbaih; Khê Hoang-Xuan; Karima Mokhtari; Roel Gw Verhaak; Paul van der Valk; Mark A van de Wiel; Jan J Heimans; Eleonora Aronica; Jaap C Reijneveld; Pieter Wesseling; Bauke Ylstra
Journal:  Genome Biol       Date:  2014-09-23       Impact factor: 13.583

10.  Reduced genomic tumor heterogeneity after neoadjuvant chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma.

Authors:  Askar Obulkasim; Bauke Ylstra; Hendrik F van Essen; Christian Benner; Sally Stenning; Ruth Langley; William Allum; David Cunningham; Imran Inam; Lindsay C Hewitt; Nicolas P West; Gerrit A Meijer; Mark A van de Wiel; Heike I Grabsch
Journal:  Oncotarget       Date:  2016-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.